Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Volatility indices capture market swings while price indices reflect level movements. This overview shows how the two guide risk-aware investing.
24,433 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Anthropic alleges Alibaba exploited thousands of fake accounts to copy AI outputs, prompting a swift stock reaction a...
With Kevin Warsh at the helm, the Fed signals a cautious but hawkish tilt. Borrowers should prepare for higher rates ...
Lam Research sits at the core of AI infrastructure tooling. This article explores whether the company could research ...
AppLovin stock has been moving decisively higher this week. Learn the catalysts, what the move signals for investors,...
Casetlake LP has offered 6.90 per share in cash for EasyJet, valuing the airline around £5.2B, but investors remain d...
Apple unveils a multiyear AI silicon plan, signaling a major shift toward in-house AI hardware. Our analysis maps a p...
A fresh recall of magsafe battery chargers recalled details new fire hazards linked to lithium-ion cells, with refund...
When a celebrity moment goes beyond fashion, it becomes a teachable moment for money. This piece breaks down the fina...
Retirees approaching 65 must act within a six-month window to secure guaranteed Medigap pricing. Missing the medigap ...
A new JPMORGAN CHASE INSTITUTE study shows american small business bills tripled in 2025 as tariff costs surged, pres...
A rising AI startup is inviting accredited investors to join a pre-IPO round at $0.85 per share before a March 12 dea...